Skip to main content
. 2019 May 10;56(3):213–227. doi: 10.1007/s10840-019-00537-8

Fig. 3.

Fig. 3

Clinical outcomes of randomised studies comparing voltage-guided ablation to standard ablation. (a) Kaplan–Meier curves comparing individualised versus standardised substrate modification, showing arrhythmia free survival and demonstrating a statistically significant benefit for an individualised approach [10]. (b) Kaplan–Meier curves from the STABLE SR trial comparing stepwise treatment for AF with substrate-based ablation using voltage mapping, showing no evidence of benefit [11]. The figures were adapted with permission